Assessment of the safety of Levilactobacillus brevis CNCM I-5321, a probiotic candidate strain isolated from pulque with anti-proliferative activities
Article in Beneficial Microbes (September 2023)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria
Article in Pharmaceutics (July 2023)
Immune modulation by probiotics in deterring carcinogenesis with an emphasis on oral cancer: A narrative review
Article in Cancer Research Statistics and Treatment (July 2023)